<?xml version="1.0" encoding="UTF-8"?>
<p>The antimicrobial activity of all synthesised compounds 
 <bold>3</bold>, 
 <bold>6</bold>, 
 <bold>8</bold> and 
 <bold>9</bold> was evaluated by agar well diffusion method
 <xref rid="CIT0035" ref-type="bibr">
  <sup>35</sup>
 </xref> using ciprofloxacin and amphotericin B as standard references for antibacterial and antifungal activity, respectively. The screening was done for the 
 <italic>in vitro</italic> antibacterial activity against Gram-positive 
 <italic>Streptococcus pneumoniae</italic> and 
 <italic>Bacillus subtilis</italic>, and Gram-negative 
 <italic>Pseudomonas aeruginosa and Escherichia coli</italic>, and for the 
 <italic>in vitro</italic> antifungal activity against 
 <italic>Aspergillus fumigates</italic> and 
 <italic>Candida albicans</italic>. The measure zones of inhibition are presented in 
 <xref ref-type="fig" rid="F0004">Figure 4</xref> in mm. By investigation of the given data, it was observed that compounds 
 <bold>3a</bold>, 
 <bold>3b</bold>, 
 <bold>6a</bold>, 
 <bold>6b</bold>, 
 <bold>8a</bold> and 
 <bold>9a</bold> displayed excellent inhibition zone diameter ranging from 11.6 to 28.7 mm against all tested strains in comparison with the reference drugs. On the other hand, the remaining derivatives showed weak or no antimicrobial activity.
</p>
